Cedar Brook Financial Partners »

Amgen shares owned by Cedar Brook Financial Partners

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Cedar Brook Financial Partners from 13F filings

Historical chart of Cedar Brook Financial Partners investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Cedar Brook Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Cedar Brook Financial Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $219k 723 302.90
2023-09-30 $200k 746 268.62
2023-03-31 $218k 903 241.63
2022-12-31 $268k 1.0k 262.51
2022-09-30 $212k 941 225.34
2022-06-30 $225k 924 243.51
2022-03-31 $231k 957 241.38
2021-12-31 $226k 1.0k 224.65
2021-09-30 $200k 941 212.54
2021-06-30 $262k 1.1k 243.49
2021-03-31 $246k 988 248.99
2020-12-31 $261k 1.1k 229.55
2020-09-30 $316k 1.2k 253.82
2020-06-30 $293k 1.2k 235.53
2020-03-31 $209k 1.0k 202.32
2019-12-31 $269k 1.1k 241.04
2019-09-30 $227k 1.2k 193.85
2019-06-30 $233k 1.3k 184.34
2019-03-31 $258k 1.4k 189.99